Literatura académica sobre el tema "Macrophage inhibitory cytokine"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Macrophage inhibitory cytokine".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Macrophage inhibitory cytokine"
Colon-Echevarria, Claudia B., Tatiana Ortiz, Lizette Maldonado, Melanie J. Hidalgo-Vargas, Jaileene Pérez-Morales, Alexandra N. Aquino-Acevedo, Roberto Herrera-Noriega, Margarita Bonilla-Claudio, Eida M. Castro y Guillermo N. Armaiz-Pena. "Zoledronic Acid Abrogates Restraint Stress-Induced Macrophage Infiltration, PDGF-AA Expression, and Ovarian Cancer Growth". Cancers 12, n.º 9 (18 de septiembre de 2020): 2671. http://dx.doi.org/10.3390/cancers12092671.
Texto completoLu, Chunxia, P. Anil Kumar, Yong Fan, Mark A. Sperling y Ram K. Menon. "A Novel Effect of Growth Hormone on Macrophage Modulates Macrophage-Dependent Adipocyte Differentiation". Endocrinology 151, n.º 5 (25 de febrero de 2010): 2189–99. http://dx.doi.org/10.1210/en.2009-1194.
Texto completoBorsini, Alessandra, Maria Grazia Di Benedetto, Juliette Giacobbe y Carmine M. Pariante. "Pro- and Anti-Inflammatory Properties of Interleukin in Vitro: Relevance for Major Depression and Human Hippocampal Neurogenesis". International Journal of Neuropsychopharmacology 23, n.º 11 (29 de julio de 2020): 738–50. http://dx.doi.org/10.1093/ijnp/pyaa055.
Texto completoKasama, Tsuyoshi, Kumiko Ohtsuka, Michihito Sato, Ryo Takahashi, Kuninobu Wakabayashi y Kazuo Kobayashi. "Macrophage Migration Inhibitory Factor: A Multifunctional Cytokine in Rheumatic Diseases". Arthritis 2010 (3 de enero de 2010): 1–10. http://dx.doi.org/10.1155/2010/106202.
Texto completoHuh, Sung Jin, Chin-Ying Chung, Arati Sharma y Gavin P. Robertson. "Macrophage Inhibitory Cytokine-1 Regulates Melanoma Vascular Development". American Journal of Pathology 176, n.º 6 (junio de 2010): 2948–57. http://dx.doi.org/10.2353/ajpath.2010.090963.
Texto completoCalandra, T., J. Bernhagen, R. A. Mitchell y R. Bucala. "The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor." Journal of Experimental Medicine 179, n.º 6 (1 de junio de 1994): 1895–902. http://dx.doi.org/10.1084/jem.179.6.1895.
Texto completoBaer, Mark, Allan Dillner, Richard C. Schwartz, Constance Sedon, Sergei Nedospasov y Peter F. Johnson. "Tumor Necrosis Factor Alpha Transcription in Macrophages Is Attenuated by an Autocrine Factor That Preferentially Induces NF-κB p50". Molecular and Cellular Biology 18, n.º 10 (1 de octubre de 1998): 5678–89. http://dx.doi.org/10.1128/mcb.18.10.5678.
Texto completoBozza, Marcelo T., Yuri C. Martins, Letícia A. M. Carneiro y Claudia N. Paiva. "Macrophage Migration Inhibitory Factor in Protozoan Infections". Journal of Parasitology Research 2012 (2012): 1–12. http://dx.doi.org/10.1155/2012/413052.
Texto completoNishi, Kosuke, Takako Ito, Ayumu Kadota, Momoko Ishida, Hisashi Nishiwaki, Naohiro Fukuda, Naoaki Kanamoto, Yoko Nagata y Takuya Sugahara. "Aqueous Extract from Leaves of Citrus unshiu Attenuates Lipopolysaccharide-Induced Inflammatory Responses in a Mouse Model of Systemic Inflammation". Plants 10, n.º 8 (19 de agosto de 2021): 1708. http://dx.doi.org/10.3390/plants10081708.
Texto completoLemay, Serge, Tatiana V. Lebedeva y Ajay K. Singh. "Inhibition of Cytokine Gene Expression by Sodium Salicylate in a Macrophage Cell Line through an NF-κB-Independent Mechanism". Clinical Diagnostic Laboratory Immunology 6, n.º 4 (1 de julio de 1999): 567–72. http://dx.doi.org/10.1128/cdli.6.4.567-572.1999.
Texto completoTesis sobre el tema "Macrophage inhibitory cytokine"
Patrikainen, Lila. "Prostatic gene expression : probasin, human prostatic acid phosphatase and macrophage inhibitory cytokine-1 as model genes /". Oulu : Oulun yliopisto, 2004. http://herkules.oulu.fi/isbn9514272730/.
Texto completoPatrikainen, L. (Lila). "Prostatic gene expression: probasin, human prostatic acid phosphatase and macrophage inhibitory cytokine-1 as model genes". Doctoral thesis, University of Oulu, 2004. http://urn.fi/urn:isbn:9514272730.
Texto completoPowell, Nicole Damico. "Immunomodulation of experimental autoimmune encephalomyelitis targeting the autoreactive T cell and the cytokine macrophage migration inhibitory factor /". Columbus, Ohio : Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1141052089.
Texto completoNguyen, Tuyet Mai. "Elucidation of thiol-protein oxidoreductase activity of the cytokine macrophage migration inhibitory factor (MIF) by biochemical redox and site-specific mutagenesis analysis". [S.l. : s.n.], 2003. http://www.bsz-bw.de/cgi-bin/xvms.cgi?SWB10520514.
Texto completoBaeza, Garcia Alvaro. "Rôle de MIF (Macrophage Migration Inhibitory Factor) dans l'immunité innée et la réponse anti-schistosome chez Biomphalaria glabrata". Phd thesis, Université du Droit et de la Santé - Lille II, 2010. http://tel.archives-ouvertes.fr/tel-00665113.
Texto completoBaía, Diogo Nogueira de Graça 1984. "Role of the LILRB1 HLA class I-specific inhibitory receptor in the regulation of macrophage function". Doctoral thesis, Universitat Pompeu Fabra, 2014. http://hdl.handle.net/10803/380898.
Texto completoEn aquest projecte hem analitzat la participació del receptor inhibidor específic per HLA de classe I: LILRB1, en la regulació de la funció dels macròfags humans (MΦ). Els macròfags M1 i M2 diferenciats in vitro expressen nivells diferents de LILRB1. Aportem evidències experimentals que recolzen el paper de la interacció LILRB1/HLA-I com element regulador del llindar d’activació en la homeòstasi del macròfag, influint en la secreció de citocines en condicions basals així com en resposta a cèl.lules tumorals i a la senyalització de receptors activadors dependents de motius ITAM. D’altra banda, les nostres observacions indiquen que el reconeixement de cèl.lules diana per part de LILRB1 es dóna independentment del nivell d’expressió de les molècules del HLA en la seva superfície, però correlaciona amb la dimerització d’aquestes molècules. Aquest canvi conformacional, detectat en MΦ tractats amb interferons de tipus I, s’associa a un increment de la interacció entre LILRB1 i HLA-I, suggerint un possible mecanisme regulador de l’activació del MΦ.
Rasiah, Krishan Kumar St Vincent's UNSW. "The identification of novel biomarkers in the development and progression of early prostate cancer". Awarded by:University of New South Wales. St Vincent's, 2006. http://handle.unsw.edu.au/1959.4/24187.
Texto completoLacey, Derek. "NFκB independent pathway activation of rheumatoid arthritis FLS by macrophage migration inhibitory factor (MIF)". Monash University, Faculty of Medicine, 2003. http://arrow.monash.edu.au/hdl/1959.1/9457.
Texto completoLo, Wing-sze y 盧詠詩. "The role of macrophage migration inhibitory factor in the pathogenesisof acute graft-versus-host disease following allogeneic bone marrowtransplantation". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2001. http://hub.hku.hk/bib/B31226413.
Texto completoMichelet, Claire. "Analyse évolutive et fonctionnelle des Macrophage Migration Inhibitory Factors chez les eucaryotes". Thesis, Université Côte d'Azur (ComUE), 2018. http://www.theses.fr/2018AZUR4109/document.
Texto completoMacrophage migration inhibitory factors (MIF) are multifunctional proteins regulating major processes in mammals, including control of the cell cycle and migration, activation of innate immune responses, and prevention of p53-mediated apoptosis. MIF proteins also play a role in innate immunity of invertebrate organisms or serve as virulence factors in parasitic organisms, raising the question of their evolutionary history and of a putative differential evolution of structure/function relationships. The general aim of this PhD was to explore the diversity and evolutionary history of MIF proteins accross kingdoms, and to investigate their potential functional differences, with a special emphasis on host-parasite systems. We first performed a broad survey of MIF presence or absence and evolutionary relationships across 803 species of plants, fungi, protists, and animals, and explored a potential relation with the taxonomic status, the ecology, and the lifestyle of individual species. We show that MIF evolutionary history in eukaryotes is complex, involving ancestral duplications, multiple gene losses and recent clade-specific re-duplications. Of note, plants and plant parasites (other than fungi) harbour a median number of three MIFs, while heterotrophic and animal parasite species harbour a lower or/and variable MIF number. Intriguingly, MIFs seem to be essential and highly conserved with many sites under purifying selection in some kingdoms (e.g. plants), while in other kingdoms they appear more dispensable (e.g. in fungi) or present in several diverged variants (e.g. insects, nematodes), suggesting potential neofunctionalizations within the protein superfamily. We then analysed the effect of MIF proteins from selected species on plant cell death. All organisms tested (plant, oomycetes, protozoa, insects, and nematodes) including species that are not in interaction with plants, possess at least one MIF protein showing a significant cell death inhibitory effect. This suggests that plant cell death inhibition does not result from a neofunctionalization of MIF from plant-parasites, and is related to conserved structural features of MIF proteins. However, none of the parameters predicted in silico (sequence motifs, 3D structures, oligomerization, post-traductional modifications) appeared to be related to the cell death inhibitory activity. Future extensive functional studies are necessary to unravel the structure-function relationship of these evolutionarily and functionally complex proteins
Libros sobre el tema "Macrophage inhibitory cytokine"
Bucala, Richard. Mif Handbook. World Scientific Publishing Co Pte Ltd, 2012.
Buscar texto completoFleischmann, Roy. Signalling pathway inhibitors. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0081.
Texto completoBerry, Martin y Ann Logan. CNS Injuries: Cellular Responses and Pharmacological Strategies (Pharmacology & Toxicology (Crc Pr)). CRC, 1998.
Buscar texto completoM, Berry y Logan Ann, eds. CNS injuries: Cellular responses and pharmacological strategies. Boca Raton: CRC Press, 1999.
Buscar texto completoCapítulos de libros sobre el tema "Macrophage inhibitory cytokine"
Feng, Lili, Byeong C. Jang y Daniel Hwang. "Inhibitor of Protein Tyrosine Kinase, Radicicol, Suprresses the Expression of Cyclooxygenase and Pro-Inflammatory Cytokines in LPS-Stimulated Rat Alveolar Macrophage in Part by Accelerating Degradation of mRNA". En Advances in Experimental Medicine and Biology, 281–88. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4899-1813-0_42.
Texto completo"Macrophage Inhibitory Cytokine 1". En Encyclopedia of Cancer, 2609. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-46875-3_101405.
Texto completoARENBERG, D. y R. BUCALA. "Macrophage migration inhibitory factor (MIF)". En The Cytokine Handbook, 1037–48. Elsevier, 2003. http://dx.doi.org/10.1016/b978-012689663-3/50049-1.
Texto completo"Macrophage Migration Inhibitory Factor (MIF )". En Cytokine Gene Polymorphisms in Multifactorial Conditions, 219–34. CRC Press, 2006. http://dx.doi.org/10.1201/9781420005325-22.
Texto completoAlourfi, Zaynab, David Ray y Rachelle Donn. "Macrophage Migration Inhibitory Factor (MIF)". En Cytokine Gene Polymorphisms in Multifactorial Conditions, 191–205. CRC Press, 2006. http://dx.doi.org/10.1201/9781420005325.ch14.
Texto completoFleischmann, Roy. "Signalling pathway inhibitors". En Oxford Textbook of Rheumatology, 630–35. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0081_update_003.
Texto completoCheng, Jianguo. "Mechanisms of Neuropathic Pain". En Neuropathic Pain, editado por Jianguo Cheng, 17–26. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190298357.003.0003.
Texto completo"Eicosanoid Inhibitor and Cytokine Regulation of 1,25(OH)2D3 Synthesis in Synovial Fluid Macrophages from Patients with Inflammatory Arthritis". En Vitamin D, 145–46. De Gruyter, 1994. http://dx.doi.org/10.1515/9783110882513-051.
Texto completoActas de conferencias sobre el tema "Macrophage inhibitory cytokine"
Karan, Dev, Seema Dubey, Jo Wick, Ossama Tawfik, Guru Sonpavde y Peter VanVeldhuizen. "Abstract B12: Macrophage inhibitory cytokine-1 as a potential biomarker for racial disparity in prostate cancer". En Abstracts: Eighth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; November 13-16, 2015; Atlanta, Georgia. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7755.disp15-b12.
Texto completoJin, Young-June, Jeong-Hyung Lee, Young-Myeong Kim, Keun-Cheol Kim y Hansoo Lee. "Abstract 3041: Macrophage inhibitory cytokine-1 stimulates proliferation of human umbilical vein endothelial cells by up-regulating Cyclins D1 and E through the PI3K/Akt- and ERK-dependent AP-1 and E2F activation signaling pathways". En Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-3041.
Texto completoSegal, Leopoldo, Rohan Kulkarni, Yoko Fujita, Anna Nolan, William N. Rom y Michael Weiden. "Azithromycin Suppresses Inflammatory Cytokines And Induces Inhibitory Transcription Factors In Alveolar Macrophages". En American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2853.
Texto completoLin, E., F. Vincent, J. Harris, R. Kandane-Rathnayake, G. S. Ngian, J. Sahhar, E. Morand y T. Lang. "THU0403 Serum levels of macrophage migration inhibitory factor and interleukin-1 family cytokines are elevated in systemic sclerosis". En Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.3272.
Texto completoCharron, Catherine, Matthew Coates, Kazuhiro Ito, Chaitanya Vuppusetty, Masako To, John Murray, Peter Strong y Garth Rapeport. "Superior Effects Of RV1088, A Novel Narrow Spectrum Kinase Inhibitor, To BIRB796, A P38MAPK Inhibitor, On Pro-Inflammatory Cytokine Production In Macrophages". En American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4538.
Texto completoCharron, Catherine, Matthew Coates, Kazuhiro Ito, Chaitanya Vuppusetty, Masako To, John Murray, Peter Strong y Garth Rapeport. "Superior Effects Of RV568, A Novel Narrow Spectrum Kinase Inhibitor, To BIRB796, A P38MAPK Inhibitor, On Pro-Inflammatory Cytokine Roduction In Macrophages". En American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3088.
Texto completoChoudhary, Shilpa, James R. Pruitt, Thais M. Sielecki, Carol Pilbeam y John Arthur Taylor. "Abstract 159: Macrophage Migration Inhibitory Factor (MIF) enhances proliferation and expression of tumorigenic cytokines in a bladder cancer cell line". En Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-159.
Texto completoKaur, Manminder, Matthew Beardsall, Michael Salmon y Dave Singh. "GS-5759, A Novel Bi-Functional Phosphodiesterase 4 Inhibitor And Long-Acting ²2-Adrenoceptor Agonist Inhibits Cytokine Production From COPD Alveolar Macrophages". En American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5705.
Texto completoSpeth, J., L. R. K. Penke, J. D. Bazzill, J. J. Moon y M. Peters-Golden. "Synthetic Liposome Mimics of Alveolar Macrophage-Derived Vesicles Containing Suppressor of Cytokine Signaling 3: Inhibitors of Lung Tumor Cell Expansion and Potential Therapeutic for Lung Cancer". En American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7433.
Texto completoDres, Martin, Alexis Ferre, Amparo Buenestado, Stanislas Grassin Delyle, Emmanuel Naline, Nicolas Roche y Philippe Devillier. "Comparison Of A Cytokine Pattern Produced By Human Lung Macrophages And Pulmonary Parenchyma Explants In Response To Lipopolysaccharide And To A Cigarette Smoke Extract. Inhibitory Effect Of Budesonide". En American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2856.
Texto completo